Health
Chinese COVID vaccine candidate based on inactivated virus appears safe, induces immune response, study finds – Medical Xpress
Results from an early-phase randomised clinical trial of a Chinese vaccine candidate based on the inactivated whole SARS-CoV-2 virus (CoronaVac) are published today…
Results from an early-phase randomised clinical trial of a Chinese vaccine candidate based on the inactivated whole SARS-CoV-2 virus (CoronaVac) are published today in The Lancet Infectious Diseases journal, finding the formulation appears safe and induces an antibody response in healthy volunteers aged 18 to 59 years.
Antibody responses could be induced within 28 days of the first immunisation, by giving two doses of the vaccine candidate 14 days apart.
The study also identifies the optimum dose…
-
Noosa News19 hours agoHow Lily Steele-Park took her rapist to court and won
-
Business24 hours agoWhere will Nvidia stock be in 1 year?
-
Business22 hours ago5 things to watch on the ASX 200 on Tuesday 8 July 2025
-
General24 hours agoAboriginal policy vacuum from Liberals, Labor as NAIDOC Week starts